Lightship is a clinical trials service provider focused on increasing access and ensuring research reflects representative populations. We partner with biopharma, CROs, and academic institutions to design and deliver studies that engage diverse and underserved patient groups, accelerating enrollment while improving patient access in clinical trials.
Through targeted outreach and education, we connect with potential participants in their community, building trust and reducing barriers to enrollment. Our decentralized and hybrid trial models, supported by our site network, mobile research units (MRUs), and mobile nursing, allow patients to take part in research that fits their lives whether at home, in a clinic, or at an MRU in the community.
By making trials more accessible and patient-centered, we reduce enrollment timelines, improve retention, and accelerate the development of therapies that better reflect real-world communities.
Company Details
- Employees
- 62
- Founded
- -
- Address
- 222 Pacific Coast Hwy, El Segundo,ca 90245,united States
- Phone
- 855-544-4820
- in****@****hip.com
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- lightship.com
- Keywords
- El Segundo.
- HQ
- El Segundo, CA
Lightship Questions
Lightship's helpline number is 855-544-4820
Lightship's website is lightship.com
Lightship's LinkedIn profile is https://www.linkedin.com/company/lightshiptrials
Lightship has
62 employees.
View email and phone details for 62
employees at Lightship.
Lightship's industry is
Research Services
Lightship's top competitors are
Parexel,
Circuit Clinical,
Science 37,
Lightship,
Iqvia,
Flatiron Health,
Medable, Inc,
Lindus Health,
Acclinate,
Curebase.
Lightship's support email address is info@lightship.com
Lightship's categories are Research Services
Lightship's founding year is 2018
